Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
We report an HIV-positive man who re-acquires hepatitis B with evidence of serological protection which then resolves while on anti-retrovirals including tenofovir.
Richardson
D
D
Jefferiss Wing, St Mary's Hospital, London W2 1NY, UK.
Lamba
H
H
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000328:Adult; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006510:Hepatitis B Antibodies / Q000097:blood; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir; D014775:Virus Activation
D006510:Hepatitis B Antibodies; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine